Sunday, February 13, 2011
Sequential vinorelbine–capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial
PurposeTo evaluate the response rate of the combination of capecitabine (C) and vinorelbine (V) followed by Docetaxel (D) in the 1st line treatment of advanced and metastatic breast cancer patients.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment